Clinical Trial Update: Post Approval Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft [NA]

View source ↗

Summary

A post-approval study of the COVERA arteriovenous stent graft for arteriovenous fistula has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arteriovenous Fistula

Drugs mentioned

• COVERA Arteriovenous Stent Graft

Snippet

Sponsor: C. R. Bard | Conditions: Arteriovenous Fistula | NA | Status: COMPLETED